NCT04810546View on ClinicalTrials.gov

Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

October 9, 2024

Study Completion Date

October 9, 2024

Conditions
Iron-deficiencyPregnancy AnemiaObesity
Interventions
DIETARY_SUPPLEMENT

Jarrow Formulas Oral Bovine Lactoferrin Supplement

Lactoferrin (Apolactoferrin) 250mg contains \~17.6 mg/100g of iron

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Illinois at Chicago

OTHER